Highlights
NASDAQ: NTLA       Intellia Thera CS
Last Price Today's Change   Day's Range   Trading Volume
17.10   -0.13 (0.75%)  16.829 - 17.31  607,100

Overview

 
Avg Volume (4 weeks):759,239
4 Weeks Range:12.778 - 17.80
4 Weeks Price Volatility (%):
86.06%
52 Weeks Range:10.26 - 19.00
52 Weeks Price Volatility (%):
78.26%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Intellia Therapeutics Inc was incorporated in Delaware in May 2014, as AZRN, Inc. In July 2014, the Company changed its name from AZRN, Inc to Interllia Therapeutics Inc. It is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. CRISPR/Cas systems include one or more proteins that cleave DNA guided by an RNA guide sequence, pieces of RNA that both recognize specific DNA sequences and activate the cleaving activity of the Cas proteins. The Company's competitors include CRISPR Therapeutics, Inc, Cellectis S.A., Cellectis S.A., and Juno Therapeutics, Inc.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers